Table 1.
Clinical characteristics of the study group on admission (n = 27)
| Clinical parameter | Value at baseline |
|---|---|
| Age (years) | 71.2 ± 11.2 (range 41.0–90.0) |
| BMI | 30.2 ± 5.4 (range 22.2–41.2) |
| QRS duration (ms) | 116.2 ± 27.0 (range 80.0–160.0) |
| Arterial hypertension (%) | 92.6 |
| Diabetes mellitus (%) | 37.0 |
| Atrial fibrillation (%) | 74.1 |
| COPD (%) | 7.4 |
| Coronary artery disease (%) | 48.1 |
| Previous myocardial infarction (%) | 37.0 |
| Previous CABG/PCI (%) | 40.7 |
| LBBB in ECG (%) | 15.4 |
| RBBB in ECG (%) | 11.5 |
| Chronic treatment with ACE-I (%) | 70.4 |
| Chronic treatment with beta-blockers (%) | 100 |
| Chronic treatment with MRA (%) | 70.4 |
Data are expressed as the mean value ± standard deviation and range for continuous variables and as a percentage of patients for qualitative variables
ACE-I angiotensin-converting enzyme inhibitors, BMI ody mass index, CABG oronary artery bypass grafting, COPD chronic obstructive pulmonary disease, MRA aldosterone receptor antagonists, PCI percutaneous coronary intervention